Evidence map›Paper›PMID 35834561›Full record

Observational studyPLoS medicine2022

Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses.

Anya Topiwala, Chaoyue Wang, Klaus P Ebmeier, Stephen Burgess, Steven Bell, Daniel F Levey, Hang Zhou, Celeste McCracken, Adriana Roca-Fernández, Steffen E Petersen and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Steatosis liver index: A validated machine learning model using clinical data distinguishes steatotic liver disease phenotypes.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Alcohol Use Disorder Affects Brain Metals.bioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Review
  15. Brain iron distribution in transdiagnostic mental health burden.PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Dietary Factors Affect Brain Iron Accumulation and Parkinson's Disease Risk.medRxiv : the preprint server for health sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Anya TopiwalaNuffield Department Population Health, Big Data Institute, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8408-0372
Chaoyue WangWellcome Centre for Integrative Neuroimaging (WIN FMRIB), Oxford University, Oxford, United Kingdom.ORCID 0000-0001-9402-1563
Klaus P EbmeierDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, United Kingdom.ORCID 0000-0002-5190-7038
Stephen BurgessMRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-5365-8760
Steven BellDepartment of Clinical Neurosciences, University of Cambridge, United Kingdom.ORCID 0000-0001-6774-3149
Daniel F LeveyDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America.ORCID 0000-0001-8431-9569
Hang ZhouDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America.ORCID 0000-0002-7694-6391
Celeste McCrackenDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.ORCID 0000-0003-1285-2393
Adriana Roca-FernándezPerspectum Diagnostics Ltd., Oxford, United Kingdom.ORCID 0000-0002-8720-9397
Steffen E PetersenWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, United Kingdom.ORCID 0000-0003-4622-5160
Betty RamanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Masud HusainWellcome Centre for Integrative Neuroimaging (WIN FMRIB), Oxford University, Oxford, United Kingdom.ORCID 0000-0002-6850-9255
Joel GelernterDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America.ORCID 0000-0002-4067-1859
Karla L MillerWellcome Centre for Integrative Neuroimaging (WIN FMRIB), Oxford University, Oxford, United Kingdom.
Stephen M SmithWellcome Centre for Integrative Neuroimaging (WIN FMRIB), Oxford University, Oxford, United Kingdom.
Thomas E NicholsNuffield Department Population Health, Big Data Institute, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-4516-5103
University of Oxford · GBYale University · USNational Institute for Health Research · GBUniversity of Cambridge · GBJohn Radcliffe Hospital · GBSt Bartholomew's Hospital · GBWarneford Hospital · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Spatial inference methods for image analysisR01EB026859 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHWARTZMAN, ARMIN · 2019 to 2022
$1.7M
Genetic Causality of Alcohol Intake and Alcohol Use Disorder on Cancer RiskR21CA252916 · NCI · YALE UNIVERSITY · PI ZHOU, HANG · 2021 to 2022
$334k
British Heart Foundation CH/12/2/29428British Heart Foundation PG/14/89/31194British Heart Foundation RG/13/13/30194British Heart Foundation RG/16/4/32218British Heart Foundation RG/18/13/33946CSRD VA I01 CX001849Department of Health BRC-1215-20014Department of Health IS-BRC-1215-20008Medical Research Council G1001354Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00002/7Medical Research Council MR/K013351/1NCATS NIH HHS UL1 TR001863NCI NIH HHS R21 CA252916NIBIB NIH HHS R01 EB026859Wellcome Trust 100309/Z/12/ZWellcome Trust 202788/Z/16/ZWellcome Trust 204623Wellcome Trust 204623/Z/16/ZWellcome Trust 206330/Z/17/ZWellcome Trust 215573/Z/19/ZWellcome Trust 216462/Z/19/Z
6 · The paper itself

Abstract

backgroundBrain iron deposition has been linked to several neurodegenerative conditions and reported in alcohol dependence. Whether iron accumulation occurs in moderate drinkers is unknown. Our objectives were to investigate evidence in support of causal relationships between alcohol consumption and brain iron levels and to examine whether higher brain iron represents a potential pathway to alcohol-related cognitive deficits. METHODS AND

findingsObservational associations between brain iron markers and alcohol consumption (n = 20,729 UK Biobank participants) were compared with associations with genetically predicted alcohol intake and alcohol use disorder from 2-sample mendelian randomization (MR). Alcohol intake was self-reported via a touchscreen questionnaire at baseline (2006 to 2010). Participants with complete data were included. Multiorgan susceptibility-weighted magnetic resonance imaging (9.60 ± 1.10 years after baseline) was used to ascertain iron content of each brain region (quantitative susceptibility mapping (QSM) and T2*) and liver tissues (T2*), a marker of systemic iron. Main outcomes were susceptibility (χ) and T2*, measures used as indices of iron deposition. Brain regions of interest included putamen, caudate, hippocampi, thalami, and substantia nigra. Potential pathways to alcohol-related iron brain accumulation through elevated systemic iron stores (liver) were explored in causal mediation analysis. Cognition was assessed at the scan and in online follow-up (5.82 ± 0.86 years after baseline). Executive function was assessed with the trail-making test, fluid intelligence with puzzle tasks, and reaction time by a task based on the "Snap" card game. Mean age was 54.8 ± 7.4 years and 48.6% were female. Weekly alcohol consumption was 17.7 ± 15.9 units and never drinkers comprised 2.7% of the sample. Alcohol consumption was associated with markers of higher iron (χ) in putamen (β = 0.08 standard deviation (SD) [95% confidence interval (CI) 0.06 to 0.09], p < 0.001), caudate (β = 0.05 [0.04 to 0.07], p < 0.001), and substantia nigra (β = 0.03 [0.02 to 0.05], p < 0.001) and lower iron in the thalami (β = -0.06 [-0.07 to -0.04], p < 0.001). Quintile-based analyses found these associations in those consuming >7 units (56 g) alcohol weekly. MR analyses provided weak evidence these relationships are causal. Genetically predicted alcoholic drinks weekly positively associated with putamen and hippocampus susceptibility; however, these associations did not survive multiple testing corrections. Weak evidence for a causal relationship between genetically predicted alcohol use disorder and higher putamen susceptibility was observed; however, this was not robust to multiple comparisons correction. Genetically predicted alcohol use disorder was associated with serum iron and transferrin saturation. Elevated liver iron was observed at just >11 units (88 g) alcohol weekly c.f. <7 units (56 g). Systemic iron levels partially mediated associations of alcohol intake with brain iron. Markers of higher basal ganglia iron associated with slower executive function, lower fluid intelligence, and slower reaction times. The main limitations of the study include that χ and T2* can reflect changes in myelin as well as iron, alcohol use was self-reported, and MR estimates can be influenced by genetic pleiotropy.

conclusionsTo the best of our knowledge, this study represents the largest investigation of moderate alcohol consumption and iron homeostasis to date. Alcohol consumption above 7 units weekly associated with higher brain iron. Iron accumulation represents a potential mechanism for alcohol-related cognitive decline.

Indexed as

AlcoholismMendelian Randomization AnalysisAlcohol DrinkingBiological Specimen BanksBrainCognitionFemaleHumansIronMaleMiddle AgedUnited KingdomIron

Identifiers

PMID35834561
PMCPMC9282660
OpenAlexW4285494354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.